Triolmezest 5/12.5/20mg

Triolmezest 5/12.5/20mg combines Olmesartan, amlodipine, and hydrochlorothiazide for the treatment of essential hypertension (high blood pressure). The triple-drug combination of the anti-hypertensive drug is for the improvement of patient compliance while treating hypertensive patients. Combination therapy is an effective strategy to increase anti-hypertensive efficacy in those patients with poor blood pressure control. To achieve blood pressure targets, your doctor may prescribe a combination therapy. Olmesartan is a class of drugs known as angiotensin II receptor antagonists, which lowers blood pressure by relaxing the blood vessels. Amlodipine also lowers blood pressure by relaxing blood vessels. Hydrochlorothiazide is a water pill that helps the body get rid of the extra fluid by making your kidney produce more urine. Lowering blood pressure reduces the risk of life-threatening complications such as strokes and myocardial infarctions. These benefits have The mechanism of action of these substances contributes to decreasing your blood pressure. The triple combination drug is effective in treating hypertension in adults whose blood pressure is not adequately controlled.